Vocal Cord Paralysis Treatment Market

Vocal cord paralysis is caused by the disruption of nerve impulses to the muscles of the larynx or voice box. Vocal cord paralysis may be caused by injury to the head, neck, or chest; lung or thyroid cancer; tumors of the neck or chest; or infection. The nerves controlling the vocal cords are long and can be vulnerable to injury in parts of the body, not usually associated with the vocal cords. The factors that are anticipated to propel the growth of the global vocal cord paralysis treatment market include the growing occurrences of the causes of vocal cord paralysis, technological advancements in the medical field, and rising healthcare expenditure. However, the high cost associated with the treatments may hinder the growth of the market during the forecast period.

The global vocal cord paralysis treatment market is expected to reach USD 2920.2 million by 2023 from USD 2334.7 million in 2017 and is expected to register a CAGR of 3.8% during the forecast period from 2018 to 2023. In 2017, the market was led by the Americas with 35.4% share, followed by Europe and Asia-Pacific with shares of 32.4% and 23.5%, respectively.

The global vocal cord paralysis treatment market has been segmented based on type, treatment, and region.

On the basis of type, Unilateral accounted for the largest market share of 89.3% in 2017, with a market value of USD 2145.1 million, which is projected to register a CAGR of 3.6% during the forecast period.

Based on treatment, voice therapy accounted for the largest market share of 62.8% in 2017, with a market value of USD 1508.7 million, which is projected to register a CAGR of 3.4%.